Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: Results of a randomized, prospective, controlled trial

Pediatrics

Volumn 112, Issue 2 I, 2003, Pages 363-367

  Bonner, Aleta B ^a,d   Monroe, Kathy W ^a   Talley, Lynya I ^c   Klasner, Ann E ^a   Kimberlin, David W ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Influenza; Patient management; Pediatric; Physician decision making

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; INFLUENZA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT INDICATION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DECISION MAKING; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INFLUENZA, HUMAN; LENGTH OF STAY; MALE; PATIENT CARE MANAGEMENT; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0041630693     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.112.2.363     Document Type: Article

References (17)

1. Long CE, Hall CB, Cunningham CK, et al. Influenza surveillance in community-dwelling elderly compared with children. Arch Fam Med. 1997;6:459-465
2. Monto AS, Sullivan KM. Acute respiratory illness in the community: frequency of illness and the agents involved. Epidemiol Infect. 1993;110:145-160
3. Frank AL, Taber LH, Glezen WP, et al. Influenza B virus infections in the community and the family. The epidemics of 1976-1977 and 1979-1980 in Houston, Texas. Am J Epidemiol. 1983;118:313-325
4. Rodriguez WJ, Schwartz RH, Thorne MM. Evaluation of diagnostic tests for influenza in a pediatric practice. Pediatr Infect Dis J. 2002;21:193-196
5. Covalciuc KA, Webb KH, Carlson CA. Comparison of four clinical specimen types for detection of influenza A and B viruses by optical immunoassay and cell culture methods. J Clin Microbiol. 1999;37:3971-3974
6. Poehling KA, Griffin MR, Dittus RS, et al. Bedside diagnosis of influenzavirus infections in hospitalized children. Pediatrics. 2002;110:83-88
7. FluOIA Test Product Package Insert. Boulder, CO: Thermo BioStar, Inc; 2001. Available at: http://www.thermo.com/eThermo/CDA/Products/Product_Detail/1,1075,13682-122, 00.html. Accessed February, 18, 2003
8. Woo PCY, Chiu SS, Seto W, Peiris M. Cost-effectiveness of rapid diagnosis of viral respiratory tract infections in pediatric patients. J Clin Microbiol. 1997;35:1579-1581
9. Adcock PM, Stout GG, Hauck MA, Marshall GS. Effect of rapid viral diagnosis on the management of children hospitalized with lower respiratory infection. Pediatr Infect Dis J. 1997;16:842-846
10. Noyola DE, Demmler GJ. Effect of rapid diagnosis on management of influenza A infections. Pediatr Infect Dis J. 2000;19:303-307
11. Sharma V, Dowd D, Slaughter AJ, Simon SD. Effect of rapid diagnosis of influenza virus type A on the emergency department management of febrile infants and toddlers. Arch Pediatr Adolesc Med. 2002;156:41-43
12. Baraff LJ. Management of fever without a source in infants and children [review]. Ann Emerg Med. 2000;36:602-614
13. Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med. 1999;340:260-264
14. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med. 1998;338:1405-1412
15. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001;20:127-133
16. Kimberlin DW, Prober CG. Antiviral agents and interferons. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases. 2nd ed. New York, NY: Churchill Livingstone; 2003:1527-1547
17. Hedrick JA, Barzilai A, Behre U, et al. Zanamivir for the treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Pediatr Infect Dis J. 2000;19:410-417